Investigative Site: #74

Arkhangelsk 163045

0 studies enrolling now · 2 studies all time

What they study most

Cervical Cancer, Cholangiocarcinoma, KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Squamous Cell Non-small Cell Lung Cancer, Urothelial Carcinoma

Studies at this site

• A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer — Completed
• A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck — Stopped early